Back

Early results of rapid-deployment aortic prosthesis in multivalvular surgery - a propensity score matching

27 August 2022 (10:15 - 11:00)
Organised by:
Congress Presentation Part of: Evolving approaches in TAVR Surgery ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Nuno Carvalho Guerra

Hospital De Santa Maria, Lisbon (Portugal)

5 More presentations in this session

Presentation thumbnail
Transcatheter aortic valve replacement in patients with a concomitant aortic aneurysm
Doctor O. Al-Taweel (Las Vegas, US)
Abstract Slides
Presentation thumbnail
Experience of the combined use of the cusp-overlap projection and auricular pacing in transcatheter aortic-valve replacement with the self-expanding valves
Doctor M. Tamargo (Madrid, ES)
Abstract Slides
Presentation thumbnail
Large comprehensive evaluation of new- vs. old-generation ACURATE neo self-expanding valve during TAVI procedures: A decrease in paravalvular leakage with an increase in post-procedural gradients?
Doctor H. Karameh (London, GB)
Abstract Slides
Presentation thumbnail
Do valve type and post-ballooning affect transprosthetic gradients in patients undergoing transcatheter aortic valve-in-valve procedure?
Doctor L. Fusini (Milan, IT)
Abstract Slides
Presentation thumbnail
Rapid deployment bioprostesis for aortic valve stenosis: single center short and long-term outcomes
Doctor R. Ferreira (Lisbon, PT)
Abstract Slides

Access the full session

Session thumbnail
Evolving approaches in TAVR

The Event

Event poster

ESC Congress 2022

27 August 2022 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Single centre experience in 1202 biological prosthesis: a comparison between sutured, sutureless and surgical transcatheter aortic valve
27 August 2021
thumbnail
Congress Presentation
Clinical outcomes associated with temporary mechanical circulatory support in the AltShock-2 registry: a propensity score matching analysis
14 March 2025
thumbnail
Congress Presentation
Reassessing surgical risk models in infective endocarditis: are they still valid beyond surgery?
21 March 2026
thumbnail
Congress Presentation
Vascular closure devices in TAVI: MANTA versus ProGlide in a propensity-matched population
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources